HBK Investments’s Avidity Biosciences RNAM Stock Holding History

HBK Investments’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,365,000	Closed	-$315M	–	385
2025 Q4	$315M	Buy	+4,365,000	New	+$282M	2.47%	12

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

HBK Investments's RNAM Position: Q1 2026 in Review

HBK Investments sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,365,000 shares — an estimated $315M sold.

HBK Investments first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $315M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

HBK Investments reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
HBK Investments sold 4,365,000 Avidity Biosciences shares in Q1 2026, an estimated $315M.
HBK Investments first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
HBK Investments's Avidity Biosciences position peaked at $315M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.